Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release; the 'Back to Top' link was removed as a minor UI change.SummaryDifference0.7%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple updates to study statuses, indicating ongoing research activities.SummaryDifference15%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.3%
- Check47 days agoChange DetectedThe page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.